$0.83
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Upexi, Inc. engages in the development, manufacturing, and distribution of consumer products through direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon. The company is headquartered in Tampa, Florida and currently employs 59 full-time employees. The company went IPO on 2021-06-24. The firm is a brand owner specializing in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space. Its brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX gummies deliver energy without the crash or jitters, offering an alternative to traditional caffeinated beverages. The company is focused on the cryptocurrency industry and the management of cash assets through a cryptocurrency portfolio, primarily focused on Solana tokens and staking of those tokens. The firm utilizes accrual mechanisms in intelligent capital issuance, staking, and discounted locked token purchases.
Country

US

CEO

Mr. Allan Marshall

IPO date

2021

Employees

59

ISIN

US39959A2050

Key stats

Open

$0.84

Volume

739.72K

Market cap

$64.34M

Prev. close

$0.81

Impl / hst vl

-

Open interest

$0.00

$0.81

Day’s Range

$0.86

$0.54

52W Range

$2.49

Valuation

44
Valuation score
Fairly Valued
P/E
-
P/S
2.46
P/B
1.32
Current ratio
1.72
Debt / Equity
-
ROE
-
Gross margin
95.47%
Income growth
-38.89%
FCF growth
-85.92

Analysts estimates

Consensus rating
Buy

The average rating from top 5 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$5.10
The top 4 analysts forecasts that 12-month price may increase by 514.46%, with a low of $2.02 and a high of $8.40
$2.02
Low
$5.10
Avg
$8.40
High
Current price

Earnings

Q1 ‘26 revenue
$4.56M
Q1 ‘26 net income
-$109.34M
Revenue
Net income
Previous EPS
-$2.94
Estimate EPS
-$0.20
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply